Industry
Medical - Devices
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Loading...
Open
2.89
Mkt cap
114M
Volume
171K
High
2.95
P/E Ratio
-1.71
52-wk high
7.84
Low
2.84
Div yield
N/A
52-wk low
2.30
Portfolio Pulse from
November 08, 2024 | 12:30 am
Portfolio Pulse from Benzinga Newsdesk
October 23, 2024 | 12:11 pm
Portfolio Pulse from Benzinga Insights
October 23, 2024 | 12:08 pm
Portfolio Pulse from Benzinga Insights
October 23, 2024 | 12:07 pm
Portfolio Pulse from Benzinga Insights
October 22, 2024 | 8:31 pm
Portfolio Pulse from Benzinga Newsdesk
October 22, 2024 | 8:28 pm
Portfolio Pulse from Benzinga Newsdesk
October 22, 2024 | 8:14 pm
Portfolio Pulse from Benzinga Insights
October 04, 2024 | 4:01 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.